Table 1 Clinical characteristics of the study patients according to gender
Women | Men | |
|---|---|---|
N | 674 | 1134 |
Age | 64.1 ± 9.6# | 61.5 ± 12.1 |
Educational level | ||
Primary middle school or lower | 306 (45.4) | 305 (26.9) |
High school and middle school | 160 (23.7) | 313 (27.6) |
Junior college or higher | 208 (30.9)# | 516 (45.5) |
Occupation | ||
Administrative | 145 (21.5) | 471 (41.5) |
Non-administrative | 106 (15.7) | 149 (13.0) |
Unemployed | 423 (62.8)# | 514 (45.5) |
Coverage rate of medical insurance | ||
0-69% | 294 (43.8) | 451 (39.9) |
≥70% | 378 (56.3)# | 680 (60.1) |
Hospital level | ||
Tertiary | 510 (75.7) | 961 (84.7) |
Secondary | 164 (24.3)# | 173 (15.3) |
Body Mass Index (kg/m 2 ) | 24.7 ± 3.6 | 25.0 ± 3.1 |
Co-morbidities | ||
CHD | 370 (54.9)# | 823 (72.6) |
PAD | 48 (7.1) | 82 (7.2) |
Stroke | 62 (9.2) | 109 (9.6) |
DM | 219 (32.5)# | 330 (29.1) |
Hypertension | 533 (79.1)# | 818 (72.1) |
Obesity (BMI ≥ 28.0) | 113 (16.8) | 162 (14.3) |
Currently smoking | 20 (3.0)# | 309 (27.2) |
Family history of premature CHD | 44 (6.5) | 60 (5.3) |
Risk stratification | ||
Low | 63 (9.3) | 77 (6.8) |
Moderate | 76 (11.3) | 53 (4.7) |
High | 300 (44.5) | 391 (34.5) |
Very high | 235 (34.9)# | 613 (54.1) |
The dosage of statin treatment | ||
Low dose | 273 (40.5) | 397 (35.0) |
Standard dose | 342 (50.7) | 628 (55.4) |
High dose | 59 (8.8) | 109 (9.6) |
Diet modification | 574 (85.2)# | 908 (80.1) |
Lipids before therapy | ||
TC (mmol/L) | 5.99 ± 1.28# | 5.18 ± 1.25 |
LDL-C (mmol/L) | 3.51 ± 1.03# | 3.08 ± 0.99 |
HDL-C (mmol/L) | 1.35 ± 0.42# | 1.15 ± 0.35 |
TG (mmol/L) | 2.15 ± 1.25 | 2.07 ± 1.61 |
Lipids after therapy | ||
TC (mmol/L) | 4.98 ± 1.12# | 4.39 ± 1.02 |
LDL-C (mmol/L) | 2.75 ± 0.87# | 2.43 ± 0.78 |
HDL-C (mmol/L) | 1.39 ± 0.41# | 1.18 ± 0.33 |
TG (mmol/L) | 1.80 ± 0.93 | 1.71 ± 1.14 |